Abstract
Chimeric transcription factors are a hallmark of human leukemia, but the molecular mechanisms by which they block differentiation and promote aberrant self-renewal remain unclear. Here, we demonstrate that the ETO2-GLIS2 fusion oncoprotein, which is found in aggressive acute megakaryoblastic leukemia, confers megakaryocytic identity via the GLIS2 moiety while both ETO2 and GLIS2 domains are required to drive increased self-renewal properties. ETO2-GLIS2 directly binds DNA to control transcription of associated genes by upregulation of expression and interaction with the ETS-related ERG protein at enhancer elements. Importantly, specific interference with ETO2-GLIS2 oligomerization reverses the transcriptional activation at enhancers and promotes megakaryocytic differentiation, providing a relevant interface to target in this poor-prognosis pediatric leukemia.
Original language | English |
---|---|
Pages (from-to) | 452-465 |
Number of pages | 14 |
Journal | Cancer Cell |
Volume | 31 |
Issue number | 3 |
DOIs | |
Publication status | Published - 13 Mar 2017 |
Externally published | Yes |
Keywords
- AMKL
- CBFA2T3
- ChIP
- CRISPR
- enhancer
- ERG
- GLIS
- leukemia
- pediatric
- transcription factor